2010美国临床肿瘤学会年会恶性血液病最新进展课件.pptVIP

* * * * * * * * * * * * * * Rituximab 375 mg/m2 d1 Gemcitabine 1000 mg/m2 d2 Oxaliplatin 100mg/m2 d2 * * * * * * * * * * * * * * * * * * * * * * * Concomitant therapy Aspirin dosed 81 mg or 325 mg daily for prevention of thrombosis Prophylaxis antiviral therapy for herpes zoster Management of peripheral neuropathy Bisphosphonates * * * DASISION: Differences in Adverse Events Rates With Dasatinib vs Imatinib Kantarjian H, et al. ASCO 2010. Abstract LBA6500. Reprinted with permission. -0.4 -0.2 0 0.2 0.4 Anemia, grade 3/4Neutropenia, grade 3/4Thrombocytopenia, grade 3/4Myalgia*NauseaVom